A randomized controlled trial for effects of collagen sponge and topical tranexamic acid in posterior lumbar fusion surgeries

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17010785

Enrollment

Unknown

Registered

2017-03-05

Start date

2013-12-02

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar degenerative disease

Interventions

1:control

2:collagen sponge

3:TXA

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Spinal degenerative disease such as lumbar stenosis, disc disease, and instability (e.g. grade I-II spondylolisthesis, spondylolisthesis /spondylolysis) which were indicated for surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Patients associated with severe medical disease such as osteoporosis, anemia, renal failure and cardiovascular disease; 2. Patients exhibited abnormal coagulation function; 3. Patients were taking antiplatelet aggregates such as Aspirin or other anticoagulants; 4. Patients has history of thromboembolism.

Design outcomes

Primary

Measure	Time frame
drainage;HGB;hospitalization;rate of transfusion;	—

Countries

China

Contacts

Public ContactShugang Li

Peking Union Medical College Hospital

lishugangpumc@163.com+86 13693339767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 8, 2026